Products
Molecule | Presentation | Status | Therapeutic Area |
Alendronic acid | 70 mg x 4 tablets | MA and Dossier | FOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE |
70 mg x 12 tablets | MA and Dossier | ||
Amoxicillin | 1 g 12 tablets | MA and Dossier | ANTIBACTERIAL FOR SYSTEMIC USE - PENICILLIN |
Amoxicillin and clavulanic acid | 875 + 125 mg tablets and sachets | MA and Dossier | ANTIBACTERIAL FOR SYSTEMIC USE - PENICILLIN IN ASSOCIATION |
pediatric sachets | Under development | ||
Atorvastatin | 10 mg x 30 tablets | MA and Dossier | MODIFYING SUBSTANCE OF LIPIDS - HMG-CoA REDUCTASE INHIBITOR - (STATIN) |
20 mg x 30 tablets | MA and Dossier | ||
40 mg x 30 tablets | MA and Dossier | ||
80 mg x 30 tablets | MA and Dossier | ||
Calcium Levofolinate | 7,5 mg x 10 tablets | Under development | THERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS - ANTIDOTE |
4 mg x 30 tablets | Under development | ||
Calcium Levofolinate Lyophilized | 25 mg vial | MA and Dossier | THERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE |
100 mg vial | MA and Dossier | ||
175 mg vial | MA and Dossier | ||
Calcium Levofolinate solution | 25 mg/2,5 ml vial | MA and Dossier | THERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE |
50 mg/ 5 ml vial | MA and Dossier | ||
100 mg/10 ml vial | MA and Dossier | ||
175 mg/17,5 ml vial | MA and Dossier | ||
Cefazolina | 1000 mg/4 ml powder and solvent for injectable solution i.m. | MA and Dossier | ANTIBACTERIAL FOR SYSTEMIC USE - CEPHALOSPORINE OF FIRST GENERATION |
Ceftazidima | 1 g/3 ml powder and solvent for injectable solution i.m. | MA and Dossier | ANTIBACTERIAL FOR SYSTEMIC USE - THIRD-GENERATION CEPHALOSPORINE |
1 g /10 ml powder and solvent for injectable solution e.v. | MA and Dossier | ||
2 g powder for solution infusion | MA and Dossier | ||
Ceftriaxone | 250 mg/ 2 ml - powder and solvent for injectable solution i.m. | MA and Dossier | ANTIBACTERIAL FOR SYSTEMIC USE - THIRD-GENERATION CEPHALOSPORINE |
500 mg/ 2 ml - powder and solvent for injectable solution i.m. | MA and Dossier | ||
1 gr/3,5 ml - powder and solvent for injectable solution i.m. | MA and Dossier | ||
1 g / 10 ml powder and solvent for injectabble solution e.v. | MA and Dossier | ||
2 g powder for solution for infusion | MA and Dossier | ||
Cilostazole | 100 mg x 28 tablets | MA and Dossier | ANTITHROMBOTIC PLASTIC ANTI-AGING |
Ciprofloxacin | 250 mg x 10 tablets | MA and Dossier | ANTIBACTERIALS FOR SYSTEMIC USE - KINOLONIC ANTIBACTERIALS |
500 mg x 6 tablets | MA and Dossier | ||
750 mg x 12 tablets | MA and Dossier | ||
Citalopram drops | 40 mg/ml | Dossier | ANTIDEPRESSANT -SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) |
Clodronic Acid + lidocaine | 100 mg / 3,3 ml 6 vials | Dossier | FOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE |
200 mg/ 4 ml 3 vials | Dossier | ||
Desketoprofene | 25 mg 20 tablets | MA and Dossier | ANTI-INFLAMMATORY AND ANTIREHUMATIC, NOT STEROID |
25 mg oral solution stick pack | MA and Dossier | ||
Dutasteride | 0,5 mg x 30 capsules | MA and Dossier | DRUG USED IN BENIGNA PROSTATIC HYPERTROPHY |
Escitalopram drops | 20 mg /ml - bottle 15 ml | MA and Dossier | ANTIDEPRESSANT - SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) |
Finasteride | 1 mg x 28 tablets | MA and Dossier | DRUG USED FOR STATES OF ANDROGENETIC ALOPECIA IN MEN |
5 mg x 15 tablets | MA and Dossier | DRUG USED IN BENIGNA PROSTATIC HYPERTROPHY | |
Fosfomycin Trometamol | 3 g granular for solution - 2 sachets | MA and Dossier | ANTIBACTERIAL FOR SYSTEMIC USE |
Furosemide | 25 mg x 30 tablets | Dossier | DIURETIC - DIURETIC FOR HIGHER DIURETIC ACTION - NON-ASSOCIATED SULPHONAMID |
500 mg x 20 tablets | Dossier | ||
Ibandronate | 150 mg x 3 tablets | MA and Dossier | FOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE |
Manidipine | 10 mg x 28 tablets | MA and Dossier | CALCIUM-ANTAGONIST |
20 mg x 28 tablets | MA and Dossier | ||
Metformina | 500 mg, 30-50 tablets | Under registration | FOR THE TREATMENT OF TYPE 2 DIABETES - BIGUANIDE |
850 mg, 30-40 tablets | Under registration | ||
850 mg, 40 tablets | Under registration | ||
1000 mg, 60 tablets | Under registration | ||
Montelukast | 10 mg x 28 tablets | MA and Dossier | FOR OBSTRUCTIVE AIRWAY SYNDROMES FOR SYSTEMIC USE - ANTAGONIST OF LEUCOTRIENIC RECEPTORS |
4 mg x 28 tablets | MA and Dossier | ||
5 mg x 28 tablets | MA and Dossier | ||
Nebivolole | 5 mg x 28 tablets | MA and Dossier | SELECTIVE BETA BLOCKER - FOR THE TREATMENT OF HYPERTENSION |
Omeprazole | 10 mg x 14-28 capsules | MA and Dossier | FOR DISORDERS RELATED TO ACID SECRETION - FOR THE TREATMENT OF PEPTIC ULCER AND GASTROESOGACEOUS REFLUX DISEASE - PROTON-PUMP INHIBITORS (PPIs) |
20 mg x 14-28 capsules | MA and Dossier | ||
40 mg x 14-28 capsules | MA and Dossier | ||
Pantoprazole (OTC) | 20 mg x 7 - 14 tablets | MA and Dossier | FOR DISORDERS RELATED TO ACID SECRETION - FOR THE TREATMENT OF PEPTIC ULCER AND GASTROESOGACEOUS REFLUX DISEASE - PROTON-PUMP INHIBITORS (PPIs) |
Paroxetine drops | 10 mg/ml oral drops, solution | Under registration | ANTIDEPRESSANT -SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) |
Prednisone | 5 mg x 20 tablets | MA and Dossier | SYSTEMIC CORTICOSTEROID - GLUCOCORTICOID |
5 mg x 10 tablets | MA and Dossier | ||
25 mg x 10 tablets | MA and Dossier | ||
VITAMIN D3 | soft gel capsules: 10.000 U.I. | Under registration | VITAMIN D |
soft gel capsules: 25.000 U.I. | Under registration | ||
soft gel capsules: 50.000 U.I. | Under registration | ||
soft gel capsules: 100.000 U.I. | Under registration | ||
injectable: 100.000 U.I. | Under registration | ||
injectable: 300.000 U.I. | Under registration |